http://rdf.ncbi.nlm.nih.gov/pubchem/patent/HU-0001263-A2
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2875 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 |
| filingDate | 1998-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ed87e1759a1bfe37cba6081c5dd85fd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62ab8dc3386919fccbb68b7b3dc34773 |
| publicationDate | 2000-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | HU-0001263-A2 |
| titleOfInvention | Procedures for Medical Applications of Anti-CD4OL Compounds |
| abstract | The present invention relates to the use of an anti-CD40L compound for the manufacture of a medicament for the treatment of patients suffering from a disease of the chronic articular disorder or of a booster, or for the suppression of a tissue rejection or transgenic product transplanted into a patient. By administering anti-CD40L compounds in triplicate or less frequently, immune system disorders can be successfully managed. ŕ |
| priorityDate | 1997-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 27.